about
C5a mediates peripheral blood neutrophil dysfunction in critically ill patientsCombined dysfunctions of immune cells predict nosocomial infection in critically ill patientsRecent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureusDiagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumoniaDifferential response to bacteria, and TOLLIP expression, in the human respiratory tract.A national survey of the diagnosis and management of suspected ventilator-associated pneumonia.Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections.Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired PneumoniaPredictive value of cell-surface markers in infections in critically ill patients: protocol for an observational study (ImmuNe FailurE in Critical Therapy (INFECT) Study).Early PREdiction of Severe Sepsis (ExPRES-Sepsis) study: protocol for an observational derivation study to discover potential leucocyte cell surface biomarkersSerial characterisation of monocyte and neutrophil function after lung resection.Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by β2-agonists, corticosteroids, and critical illness.Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an emergency department.Use of enoximone in management of anaphylaxis complicated by labetalol use.Comment on "changes and regulation of the C5a receptor on neutrophils during septic shock in humans".Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.16S pan-bacterial PCR can accurately identify patients with ventilator-associated pneumonia.Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey.Immune Activation in Sepsis.Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial.Triage during pandemic influenza: seeking absolution in numbers?Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study.Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort studyC5a anaphylatoxin and its role in critical illness-induced organ dysfunctionRandomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosisA global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysisPulmonary and systemic effects of mononuclear leukapheresisA novel subpopulation of monocyte-like cells in the human lung after lipopolysaccharide inhalationPain in medical inpatients: an under-recognised problem?Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lungAntimicrobial-associated harm in critical care: a narrative review
P50
Q28239494-049337DF-5434-4E70-A8D9-A3C132FFFBF5Q28292476-857B022D-A02C-471E-9B70-81539CB8E08DQ30382219-B3CC4078-AE25-4077-B2E9-8E7980F8B11AQ33838052-4D1A5367-D457-4ED5-A925-36FC8D941435Q34419643-D2C16ACB-0711-4EDC-95EA-FB73E547695CQ34767855-D065421C-473E-4864-A664-9748EA5CB35FQ35875094-4986F4D4-CCEB-4453-A739-4E8AEF8C3BC5Q36676363-68885998-5E48-4B52-AC02-36231AA299CBQ37133921-CEE781D3-AC83-4237-A330-1BEC69C467FFQ37177606-46DA456F-68C9-4B92-9C2E-9D806C3BB823Q39082960-8C6575F2-6593-4A77-B846-3AD6719779B3Q40990440-13EDDB91-4420-45E6-85E8-5415E25D3DA2Q42248698-9D095786-E8C7-4837-B41F-1B94C9BD18FDQ42830512-1DF7476B-3EA7-4736-987D-A1523219E50DQ43183810-6ABFAF85-F302-4345-B201-3FE114E46D7FQ45283648-EAF70897-3C30-4879-AEC5-B9F4A3330B10Q47134075-75A16A3D-880E-4738-81C9-D6745F348A35Q47155676-EB53CFBB-FA19-4839-9FBD-18C1953BFCD5Q47213441-1A5A8B5E-2737-43CC-AB48-27285A705AABQ47229751-5C38403D-F8B5-4A79-952D-2D8D59B035D0Q47598351-3AB01505-332F-45D4-A368-AF8C15756431Q47702061-E0692623-E7C7-4AA7-86DA-8AFEED72333CQ55417565-735E5371-06DC-4968-A8FF-08682BC6674FQ57021855-04DA4053-6924-4879-980C-C205037BC30EQ60129019-A62C37DB-A5BC-4AD3-9EC1-E0A47D86D8CDQ60358206-EDE73324-1E54-4CA9-9EC8-F973B6035EA2Q64027928-D84CE64E-9659-452C-B151-8EDBB722A23BQ64464956-1ED2E3C1-F36F-470A-8EB8-3E8DCB4C3DB5Q64464961-0F6B58F4-F35A-4DF8-A008-FE8C84D16E01Q82858652-BB205227-9D54-44AC-86A3-5F64C2F24368Q84842383-4B5447D6-66F9-46C0-BF73-BB2330B8FA6EQ93041251-B26ADE5B-9245-48F6-8A23-2202628F4223
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrew Conway Morris
@ast
Andrew Conway Morris
@en
Andrew Conway Morris
@es
Andrew Conway Morris
@fr
Andrew Conway Morris
@nl
Andrew Conway Morris
@sl
type
label
Andrew Conway Morris
@ast
Andrew Conway Morris
@en
Andrew Conway Morris
@es
Andrew Conway Morris
@fr
Andrew Conway Morris
@nl
Andrew Conway Morris
@sl
prefLabel
Andrew Conway Morris
@ast
Andrew Conway Morris
@en
Andrew Conway Morris
@es
Andrew Conway Morris
@fr
Andrew Conway Morris
@nl
Andrew Conway Morris
@sl
P106
P1153
26648110100
P21
P31
P3835
andrew-conway-morris
P496
0000-0002-3211-3216